MHM Magazine

S5 BUDEP XR 150 Extended Release Tablets. Reg. No.: 48/1.2/0114. Each extended release tablet contains 150 mg bupropion hydrochloride. Contains sugar: lactose monohydrate. S5 BUDEP XR 300 Extended Release Tablets. Reg. No.: 48/1.2/0115. Each extended release tablet contains 300 mg bupropion hydrochloride. Contains sugar: lactose monohydrate. Pharmacological classification: A. 1.2. Psycho-analeptics (antidepressants). For full prescribing information, refer to the Professional Information Leaflet approved by the Regulatory Authority. Applicant: Ranbaxy Pharmaceuticals (Pty) Ltd, 14 Lautre Road, Stormill, Ext.1, Roodepoort, 1724. Tel: +27 11 495-0100. Fax: +27 12 495-0150 . www.sunpharma.com References: 1 . Data on file. Budep global ranking. 2. Budep Site Approval. 3. Fava M, Rush J, Thase ME, et al. 15 years of clinical experience with bupropion HCl: From bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 2005:7:106-113. 4. Clayton AH, Croft HA, Horrigan JP, et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006;67(5):736-746. 5. Data on File (SITES) Effective antidepressant with dual effect on noradrenaline and dopamine reuptake 3 Little or no weight gain 3 Preserves sexual functioning 4 XR Bupropion 150 / 300 mg Budep Present in over 6 countries Bupropion from Sun Pharma is ranked 6th globally in the bupropion market 1 Globally trusted brand with USFDA and EU site approval 2 EU – European Union; USFDA – United States Food and Drug Administration